ACADIA Pharmaceuticals's total assets for Q4 2024 were $1.19B, an increase of 21.59% from the previous quarter. ACAD total liabilities were $454.96M for the fiscal quarter, a 13.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.